ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC) trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to spare patients major esophagus surgery
Disease control Recruiting nowThis study is testing whether a combination of cancer drugs can shrink tumors enough to allow doctors to remove early-stage esophageal cancer using a less invasive, tube-based procedure instead of major surgery. The goal is to preserve the esophagus and avoid a large operation. T…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
New hope for frail elderly with aggressive throat cancer
Disease control Recruiting nowThis study is testing a drug called tislelizumab for elderly patients with advanced esophageal cancer who are too frail for standard chemotherapy. The goal is to see if this immunotherapy, given by IV infusion, can help control the cancer and extend life. Researchers will measure…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope for Tough-to-Treat esophageal cancer?
Disease control Recruiting nowThis study is testing whether adding two new immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy works better for advanced esophageal cancer that has returned or spread. It will involve about 25 adults who haven't had prior treatment for their advanced can…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope for inoperable esophageal cancer: drug combo aims to shrink tumors for surgery
Disease control Recruiting nowThis study is testing whether a drug called tislelizumab, combined with standard chemotherapy and radiation, can shrink advanced esophageal cancer tumors enough to make surgery possible. The goal is to control the disease and improve survival for patients who currently have no su…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Ming-Yu Lien • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radioactive cancer fighter enters human testing for tough tumors
Disease control Recruiting nowThis early-stage trial is testing a new radioactive drug called 177LuBetaBart in adults with advanced solid cancers that have stopped responding to standard treatments. The study aims to find a safe dose and see if the drug shows early signs of fighting tumors. Participants will …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1, PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First patients to receive new 'Smart Bomb' cancer drug in groundbreaking trial
Disease control Recruiting nowThis is the first study in people to test a new experimental cancer drug called ALX2004. It aims to find a safe dose and see if the drug can help control advanced cancers that have spread and stopped responding to other treatments. The trial will enroll about 170 adults with spec…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Faster radiation schedule tested in battle against tough esophageal cancer
Disease control Recruiting nowThis study is for people with advanced esophageal cancer that cannot be removed by surgery. It aims to see if a shorter, more intense course of radiation combined with chemotherapy and immunotherapy works better and is as safe as the standard, longer radiation schedule. All parti…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Scientists aim to zap esophageal cancer with stronger, targeted radiation
Disease control Recruiting nowThis early-stage trial is testing if giving a higher, more precise dose of radiation can better control a type of esophageal cancer. It will involve about 30 patients who are already scheduled for standard chemotherapy, radiation, and surgery. The main goal is to find the highest…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Phase: PHASE1 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
One blood test for six cancers? new study aims to revolutionize early detection
Diagnosis Recruiting nowThis study aims to develop a simple blood test to detect six different gastrointestinal cancers earlier than current methods. Researchers will analyze blood samples from 1,000 people, including those with cancer and healthy controls, to find tiny genetic signals that indicate can…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC